The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Drug Toxicity (Toxicology) - Drugs in Development, 2021
US$ 2,000.00
Drug Toxicity (Toxicology) - Drugs in Development, 2021 SUMMARY Drug Toxicity (Toxicology) - Drugs in Development, 2021 provides an overview of the Drug Toxicity pipeline landscape. The report provide...
April 2021
45 pages
Edema (Cardiovascular) - Drugs in Development, 2021
US$ 2,000.00
Edema (Cardiovascular) - Drugs in Development, 2021 SUMMARY Edema (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Edema pipeline landscape. The report provides comprehensive...
April 2021
35 pages
Emphysema (Respiratory) - Drugs in Development, 2021
US$ 2,000.00
Emphysema (Respiratory) - Drugs in Development, 2021 SUMMARY Emphysema (Respiratory) - Drugs in Development, 2021 provides an overview of the Emphysema pipeline landscape. The report provides comprehe...
April 2021
45 pages
Endocarditis (Cardiovascular) - Drugs in Development, 2021
US$ 2,000.00
Endocarditis (Cardiovascular) - Drugs in Development, 2021 SUMMARY Endocarditis (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Endocarditis pipeline landscape. The report pr...
April 2021
30 pages
Enteritis (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Enteritis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Enteritis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Enteritis pipeline landscape. The report provide...
April 2021
30 pages
Ependymoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Ependymoma (Oncology) - Drugs in Development, 2021 SUMMARY Ependymoma (Oncology) - Drugs in Development, 2021 provides an overview of the Ependymoma pipeline landscape. The report provides comprehensi...
April 2021
55 pages
Epidermal Growth Factor (EGF) - Drugs in Development, 2021
US$ 3,000.00
Epidermal Growth Factor (EGF) - Drugs in Development, 2021 SUMMARY Epidermal Growth Factor (EGF) - Drugs in Development, 2021 provides in depth analysis on Epidermal Growth Factor (EGF) targeted pipel...
April 2021
35 pages
